Skip to main content

CORRECTION article

Front. Psychiatry, 14 February 2022
Sec. Psychological Therapy and Psychosomatics
Volume 13 - 2022 | https://doi.org/10.3389/fpsyt.2022.837357

Corrigendum: The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease

This article is a correction to:

  1. The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease

    1. Read original article
\nInês A. Trindade, &#x;Inês A. Trindade1,2*†Joana Pereira&#x;Joana Pereira1†Ana Galhardo,Ana Galhardo1,3Nuno B. FerreiraNuno B. Ferreira4Paola Lucena-SantosPaola Lucena-Santos1Srgio A. Carvalho,Sérgio A. Carvalho1,5Sara OliveiraSara Oliveira1David SkvarcDavid Skvarc6Brbara S. RochaBárbara S. Rocha7Francisco PortelaFrancisco Portela8Cludia Ferreira Cláudia Ferreira1*
  • 1Faculty of Psychology and Education Sciences, CINEICC, University of Coimbra, Coimbra, Portugal
  • 2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
  • 3Instituto Superior Miguel Torga, Coimbra, Portugal
  • 4School of Social Sciences, University of Nicosia, Nicosia, Cyprus
  • 5Universidade Lusófona de Humanidades e Tecnologias, Escola de Psicologia e Ciências da Vida, HEI-Lab, Lisbon, Portugal
  • 6School of Psychology, Deakin University, Geelong, VIC, Australia
  • 7Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal
  • 8Gastroenterology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal

A Corrigendum on
The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease

by Trindade, I. A., Pereira, J., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Oliveira, S., Skvarc, D., Rocha, B. S., Portela, F., and Ferreira, C. (2021). Front. Psychiatry 12:699367. doi: 10.3389/fpsyt.2021.699367

In the original article, Figure 1 was not correctly presented. The participant flow was not correctly calculated and reported, in particular to what concerned the number of participants from the experimental group with complete baseline assessments. This mistake was identified in the beginning of the conduction of the RCT's statistical analyses, after the present study protocol was published. The flow diagram has been updated and re-designed according to CONSORT 2010 guidelines. The corrected Figure 1 appears below.

FIGURE 1
www.frontiersin.org

Figure 1. CONSORT 2010 flow diagram. *Participants with three consecutive absences or who attended less than two-thirds of the intervention were considered non-completers.

In the paragraph “Randomization of Participants”, the information provided in the last sentence was incomplete. As originally reported, before the start of the intervention, six patients self-excluded from the study due to a lack of resources to attend the sessions (e.g., lack of time, transportation). In addition to these participants, other 6 participants also dropped out from the study without providing a reason. A correction has been made to this paragraph:

Randomization of Participants

Figure 1 shows the flow of participants through the study. Of the 355 patients screened, 279 were excluded for not meeting criteria to participate. Seventy-six participants were randomly assigned to one of two conditions: experimental group (Treatment as Usual + LIFEwithIBD intervention: n = 38) or control group (TAU: n = 38), through computed-based randomization (www.random.org/lists/). Before the start of the intervention, twelve participants self-excluded from the study; half provided reasons for dropping out, such as lack of time, lack of transportation, or unavailability due to overlapping schedules.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: acceptance and commitment therapy, compassion, inflammatory bowel disease, mindfulness, randomized controlled trial, study protocol

Citation: Trindade IA, Pereira J, Galhardo A, Ferreira NB, Lucena-Santos P, Carvalho SA, Oliveira S, Skvarc D, Rocha BS, Portela F and Ferreira C (2022) Corrigendum: The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease. Front. Psychiatry 13:837357. doi: 10.3389/fpsyt.2022.837357

Received: 16 December 2021; Accepted: 14 January 2022;
Published: 14 February 2022.

Edited and reviewed by: Georgios Paslakis, Ruhr University Bochum, Germany

Copyright © 2022 Trindade, Pereira, Galhardo, Ferreira, Lucena-Santos, Carvalho, Oliveira, Skvarc, Rocha, Portela and Ferreira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Inês A. Trindade, ines.almeidatrindade@gmail.com; Cláudia Ferreira, claudiaferreira@fpce.uc.pt

†These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.